Share

The key list

Powered by

Leading companies in China by market cap

This month our pharma industry key list brings you the 15 largest companies in China by market cap, as ranked by GlobalData's Pharma Intelligence Centre. All numbers as of August 2020.


Company nameMarket cap ($million)Headquarters locationNumber of employees

Jiangsu Hengrui Medicine Co Ltd

56,041China24,700

WuXi Biologics Ltd

16,350China4,512

CSPC Pharmaceutical Group Ltd

14,847China-

Chongqing Zhifei Biological Products Co Ltd

11,503China2,405

Shanghai Fosun Pharmaceutical (Group) Co Ltd

9,429China31,370

Walvax Biotechnology Co Ltd

7,221China1,089

Hualan Biological Engineering Inc

7,140China2,144

Shanghai Pharmaceutical Co Ltd

6,924China47,620

Sichuan Kelun Pharmaceutical Co Ltd

4,896China19,990

Chengdu Kanghong Pharmaceuticals Group Co Ltd

4,687China4,201

Innovent Biologics Inc

4,263China1,445

Beijing Tiantan Biological Products Co Ltd

4,229China-

Livzon Pharmaceutical Group Co Ltd

4,008China7,671

Betta Pharmaceuticals Co Ltd

3,814China1,160

Tonghua Dongbao Pharmaceutical Co Ltd

3,725China2,651

Share this article

Go to article: Home | Pause for thoughtGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: NewsGo to article: BaxterGo to article: Covid-19 executive briefing by GlobalDataGo to article: ELPRO Monitoring SolutionsGo to article: Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for successGo to article: Abiomed’s Impella receives FDA Emergency Use Authorization during Covid-19Go to article: FargoGo to article: Disruptions to global oncology trials have fallen to a three-month lowGo to article: MimotopesGo to article: AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine cliGo to article: Biotech IPO valuation relies on data to enter capital markets during Covid-19 paGo to article: Nelson LabsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: A century of cultures: celebrating the world’s oldest lab culture collectionGo to article: SkyepharmaGo to article: Gut feeling: exploring the therapeutic potential of the gut-brain axisGo to article: OptelGo to article: Crabby concoctions: why pharma’s thirst for crustacean blood is up for debateGo to article: Air FranceGo to article: Debunking myths about puberty blockers for transgender childrenGo to article: MicronovaGo to article: Hiring from home: pharma recruitment in the age of Covid-19 Go to article: Nipro PharmapackagingGo to article: Q&A: breaking new ground in pharma packaging with HoneywellGo to article: WipotecGo to article: Treatment-resistant rare diseases: exploring landmark drug approvals in 2020Go to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Modernising pharma patents: can AI be an inventor?Go to article: ILC Dover Go to article: Boosting agility to accelerate project timescales Go to article: Scandinavian HealthGo to article: Doing the right thing: the enhanced case for complianceGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue